Advertisement
Screener

INVESCO DB BASE METALS FUND (DBB) Marketable Securities, Realized Gain (Loss), Excluding Other-than-temporary Impairment Loss

INVESCO DB BASE METALS FUND Marketable Securities, Realized Gain (Loss), Excluding Other-than-temporary Impairment Loss

INVESCO DB BASE METALS FUND (DBB) reported Marketable Securities, Realized Gain (Loss), Excluding Other-than-temporary Impairment Loss of $12.78 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-07.

Financial Statements › Income Statement › Other Income

us-gaap:MarketableSecuritiesRealizedGainLossExcludingOtherThanTemporaryImpairments · last filed 2026-08-07

  • INVESCO DB BASE METALS FUND marketable securities, realized gain (loss), excluding other-than-temporary impairment loss for the quarter ending 2026-06-30 was $12.78M.
  • INVESCO DB BASE METALS FUND marketable securities, realized gain (loss), excluding other-than-temporary impairment loss for the quarter ending 2026-03-31 was $13.47M.
  • INVESCO DB BASE METALS FUND marketable securities, realized gain (loss), excluding other-than-temporary impairment loss for the quarter ending 2025-12-31 was $9.91M, a 3529.35% increase year-over-year.
  • INVESCO DB BASE METALS FUND marketable securities, realized gain (loss), excluding other-than-temporary impairment loss for the quarter ending 2025-09-30 was $2.55M, a 1256.03% increase year-over-year.
  • INVESCO DB BASE METALS FUND marketable securities, realized gain (loss), excluding other-than-temporary impairment loss for fiscal 2025 was $5.15M, a 26.97% decline from fiscal 2024.
  • INVESCO DB BASE METALS FUND marketable securities, realized gain (loss), excluding other-than-temporary impairment loss for fiscal 2024 was $7.05M.
  • INVESCO DB BASE METALS FUND marketable securities, realized gain (loss), excluding other-than-temporary impairment loss for fiscal 2023 was -$55.58M, a 365.69% decline from fiscal 2022.
  • INVESCO DB BASE METALS FUND marketable securities, realized gain (loss), excluding other-than-temporary impairment loss for fiscal 2022 was $20.92M, a 68.52% decline from fiscal 2021.
Period endMarketable Securities, Realized Gain (Loss), Excluding Other-than-temporary Impairment Loss 3 monthMarketable Securities, Realized Gain (Loss), Excluding Other-than-temporary Impairment Loss 6 monthMarketable Securities, Realized Gain (Loss), Excluding Other-than-temporary Impairment Loss 9 monthMarketable Securities, Realized Gain (Loss), Excluding Other-than-temporary Impairment Loss 12 month
2026-06-30$12.78M
10-Q · filed 2026-08-07
$26.25M
10-Q · filed 2026-08-07
$36.15M
derived: sum of 3 quarters · filed 2026-08-07
$38.70M
derived: sum of 4 quarters · filed 2026-08-07
2026-03-31$13.47M
10-Q · filed 2026-05-07
$23.37M
derived: sum of 2 quarters · filed 2026-05-07
$25.92M
derived: sum of 3 quarters · filed 2026-05-07
$18.72M
derived: sum of 4 quarters · filed 2026-08-07
2025-12-31$9.91M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-02
$12.45M
derived: sum of 2 quarters · filed 2026-03-02
$5.25M
derived: sum of 3 quarters · filed 2026-08-07
$5.15M
10-K · filed 2026-03-02
2025-09-30$2.55M
10-Q · filed 2025-11-07
-$4.65M
derived: sum of 2 quarters · filed 2026-08-07
-$4.76M
10-Q · filed 2025-11-07
-$4.48M
derived: sum of 4 quarters · filed 2026-08-07
2025-06-30-$7.20M
10-Q · filed 2026-08-07
-$7.30M
10-Q · filed 2026-08-07
-$7.03M
derived: sum of 3 quarters · filed 2026-08-07
-$6.84M
derived: sum of 4 quarters · filed 2026-08-07
2025-03-31-$102.66K
10-Q · filed 2026-05-07
$170.27K
derived: sum of 2 quarters · filed 2026-05-07
$358.06K
derived: sum of 3 quarters · filed 2026-05-07
$7.08M
derived: sum of 4 quarters · filed 2026-05-07
2024-12-31$272.93K
derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-02
$460.72K
derived: sum of 2 quarters · filed 2026-03-02
$7.18M
derived: sum of 3 quarters · filed 2026-03-02
$7.05M
10-K · filed 2026-03-02
2024-09-30$187.79K
10-Q · filed 2025-11-07
$6.90M
derived: sum of 2 quarters · filed 2025-11-07
$6.78M
10-Q · filed 2025-11-07
$4.46M
derived: sum of 4 quarters · filed 2026-03-02
2024-06-30$6.72M
10-Q · filed 2025-08-07
$6.59M
10-Q · filed 2025-08-07
$4.27M
derived: sum of 3 quarters · filed 2026-03-02
-$6.14M
derived: sum of 4 quarters · filed 2026-03-02
2024-03-31-$128.85K
10-Q · filed 2025-05-08
-$2.45M
derived: sum of 2 quarters · filed 2026-03-02
-$12.86M
derived: sum of 3 quarters · filed 2026-03-02
-$43.65M
derived: sum of 4 quarters · filed 2026-03-02
2023-12-31-$2.32M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-02
-$12.73M
derived: sum of 2 quarters · filed 2026-03-02
-$43.52M
derived: sum of 3 quarters · filed 2026-03-02
-$55.58M
10-K · filed 2026-03-02
2023-09-30-$10.41M
10-Q · filed 2024-11-07
-$41.20M
derived: sum of 2 quarters · filed 2024-11-07
-$53.26M
10-Q · filed 2024-11-07
-$75.82M
derived: sum of 4 quarters · filed 2025-02-26
2023-06-30-$30.79M
10-Q · filed 2024-08-07
-$42.85M
10-Q · filed 2024-08-07
-$65.41M
derived: sum of 3 quarters · filed 2025-02-26
-$102.37M
derived: sum of 4 quarters · filed 2025-02-26
2023-03-31-$12.06M
10-Q · filed 2024-05-08
-$34.62M
derived: sum of 2 quarters · filed 2025-02-26
-$71.58M
derived: sum of 3 quarters · filed 2025-02-26
-$5.91M
derived: sum of 4 quarters · filed 2025-02-26
2022-12-31-$22.56M
derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-26
-$59.52M
derived: sum of 2 quarters · filed 2025-02-26
$6.16M
derived: sum of 3 quarters · filed 2025-02-26
$20.92M
10-K · filed 2025-02-26
2022-09-30-$36.96M
10-Q · filed 2023-11-08
$28.72M
derived: sum of 2 quarters · filed 2023-11-08
$43.48M
10-Q · filed 2023-11-08
$46.59M
derived: sum of 4 quarters · filed 2024-02-23
2022-06-30$65.68M
10-Q · filed 2023-08-04
$80.44M
10-Q · filed 2023-08-04
$83.55M
derived: sum of 3 quarters · filed 2024-02-23
$97.27M
derived: sum of 4 quarters · filed 2024-02-23
2022-03-31$14.76M
10-Q · filed 2023-05-09
$17.88M
derived: sum of 2 quarters · filed 2024-02-23
$31.59M
derived: sum of 3 quarters · filed 2024-02-23
$81.21M
derived: sum of 4 quarters · filed 2024-02-23
2021-12-31$3.11M
derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-23
$16.83M
derived: sum of 2 quarters · filed 2024-02-23
$66.44M
derived: sum of 3 quarters · filed 2024-02-23
$66.44M
10-K · filed 2024-02-23
2021-09-30$13.71M
10-Q · filed 2022-11-04
$63.33M
derived: sum of 2 quarters · filed 2022-11-04
$63.33M
10-Q · filed 2022-11-04
2021-06-30$49.62M
10-Q · filed 2022-08-05
$49.62M
10-Q · filed 2022-08-05
2020-12-31-$9.03M
10-K · filed 2023-02-24
2019-12-31-$23.95M
10-K · filed 2022-02-25

Similar stocks